Maravai Lifesciences Holdings, Inc. (MRVI)
Maravai LifeSciences makes nucleic acid products and bioprocess testing kits and services for drug developers and researchers. It last closed at $7.28 on Nov 17, down 1.62% on the day. The average 12-month price target from 2 analysts is $9.50 (+30.5% from the last close), with a high of $11.00 and a low of $8.00. In the past 30 days there were 2 dark pool prints totaling $578K, the largest $299K.
Key Stats
Last 12 monthsNot reported for this period.
From MRVI's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 2 analysts who set a price target on MRVI in the past 90 days. The average target is $9.50, with a high of $11.00 and a low of $8.00, compared with the last close of $7.28.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 12 | Keybanc | Upgrade | Buy | $11 |
| Sep 9 | UBS | Maintained | Hold | $8 |
| Aug 7 | Wells Fargo | Maintained | Buy | $6.50 |
Technical Analysis
The stock is 5% below its 20 day and 2% below its 50 day average. It is 25% above its 200 day average, so the longer trend is still up. Momentum is fading (RSI 47). The nearest support is the Pivot S1 at $7.14, and the nearest resistance the Pivot at $7.31.
| RSI (14) | 46.74 | Middle of its range | Neutral |
| MACD | 0.02 | Below its signal line | Bearish |
| Stochastic | 33.3 | Middle of its range | Neutral |
| ADX (14) | 10.6 | No clear trend | |
| Williams %R | -73.6 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | -71.9 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | −2.3% | Change over 10 sessions | Bearish |
| ATR (14) | $0.50 | Typical daily range, 6.9% of price |
| RSI (14) | 55.72 | Middle of its range | Neutral |
| MACD | 0.65 | Below its signal line | Bearish |
| Stochastic | 49.8 | Middle of its range | Neutral |
| ADX (14) | 37.6 | Trending up | |
| Williams %R | -55.0 | Oversold below −80, overbought above −20 | Neutral |
| CCI (20) | 23.2 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | +11.5% | Change over 10 sessions | Bullish |
| ATR (14) | $0.94 | Typical daily range, 12.8% of price |
What happened before
See how MRVI did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How MRVI has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2020.
Whale Options Flow
90DNo whale options trades in MRVI in the last 90 days.
Dark Pool
30DMRVI Institutional Ownership
Full report →- ▲122 buying vs 82 selling
- ●Shares held by funds +1.0%
- ▲Funds holding +23
- ●Superinvestors: 2 added, 2 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 203 | 180 | +12.8% |
| In funds' top 10 | 2 | 4 | −50.0% |
| Held by funds | – | – | – |
| New / increased | 52 / 70 | 46 / 57 | +18.4% |
| Reduced / sold out | 53 / 29 | 51 / 23 | +10.8% |
| Put/call ratio | 0.00 | 0.00 | – |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MRVI is in one of them and how their past MRVI trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered MRVI in an article yet. Here's the latest on the wider market.
MRVI Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Dan GoldmanD · NY | Sell | $1K – $15K | Apr 10, 2023 | May 19, 2023 | 39 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Maravai Lifesciences Holdings
Maravai LifeSciences is a life sciences company based in San Diego, California. Its TriLink segment makes modified nucleic acids for customers' research, therapeutic and vaccine programs, and sells research products for labeling and detecting proteins in cells and tissue samples. Its Cygnus segment sells kits and products for testing biologic drug manufacturing, including host cell protein and impurity detection and viral clearance prediction, and offers services such as custom antibody development and mass spectrometry. Its customers include drug developers, vaccine makers, researchers and biologic drug manufacturers.
- Headquarters
- San Diego, CA
- Website
- maravai.com ↗




